Back to Selection     Print       Date : 30 Jun 2026
Fund Summary
HDFC Large And Mid Cap Fund Reg (G)
[Equity: Large & Mid Cap]  
 
Fund Details
Fund Type Growth Launch Date 18-Feb-94
Corpus(Cr.) 28515.0 Latest NAV 348.745 As on 29-07-2026
Equity(%) 99.3 52 Week High 353.201
Debt(%) 0.7 52 Week Low 299.391
Others(%) 0.0 Exit Load 1% for redemption within 365 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.35
Scheme Benchmark NIFTY Large Midcap 250 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Gopal Agrawal
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation/income from a portfolio, predominantly invested in equity and equity related instruments.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 13.05%
Top 10 Holdings 20.20%
Top 25 Holdings 36.37%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 19.14
Pharma & Biotech 10.75
Finance & Investments 8.19
Automobile 8.15
Software & Services 5.86
Retail 5.82
Miscellaneous 3.22
Construction 3.05
Telecom 3.0
Petroleum Products 2.86
Healthcare 2.82
Energy 2.67
Chemicals 2.51
Agricultural & Farm Machinery 2.2
Consumer Durables 2.17
Industrial Products 2.04
Ferrous Metals 1.76
Transportation 1.57
FMCG 1.47
Aerospace & Defence 1.46
Electricals 1.45
Oil & GAS 1.38
SERVICES 1.25
Fertilisers 0.98
Metals 0.78
Food Beverage & Tobacco 0.7
Cash 0.7
Technology 0.5
Communication 0.42
Media & Entertainment 0.41
Realty 0.35
Textiles 0.25
Equity MF 0.12
 
 
 
 
 
Portfolio Metrics
PB Ratio 2.85
PE Ratio 21.20
 
Top 25 Holdings
Holdings Net Asset(%)
HDFC Bank Limited 4.00
ICICI Bank Limited 3.71
Axis Bank Limited 1.95
Bharti Airtel 1.84
Fortis Health Care Ltd 1.55
Reliance Industries Limited 1.51
State Bank of India 1.48
Max Financial Services Limited 1.41
Maruti Suzuki India Limited 1.41
Prestige Estates Projects Limited 1.34
Gland Pharma Limited 1.19
INDUSIND BANK 1.19
Lupin Limited 1.16
Aurobindo Pharma Limited 1.16
Shriram Finance Limited 1.15
Mphasis Limited 1.14
Kotak Mahindra Bank Limited 1.13
Infosys Limited 1.10
MAHINDRA & MAHINDRA FINANCIAL 1.06
Ajanta Pharma Limited 1.05
Larsen & Toubro Limited 1.03
Bharat Forge Limited 0.99
Hindustan Petroleum Corp. Ltd. 0.98
Eternal Limited 0.94
Inter Globe Aviation Ltd 0.90

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
2.44% 4.34% 3.24% 2.78%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.46% 0.94% -3.91% -1.20%
 
Scheme Benchmark [NSE - Nifty Large Midcap 250 TRI]
1.79% 2.88% 2.92% 4.38%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
1.07% 14.24% 15.56% 14.43%
 
 
0.01% 8.55% 10.25% 12.21%
 
 
2.05% 14.59% 14.50% 15.19%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
HDFC Large And Mid Cap Fund Reg (G) 16.29% 0.5173 13.2253% 42.0624 0.0841
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
HDFC Large And Mid Cap Fund Reg (G) 6.3591% 0.0005 0.0896 7.4222 1.1798
 
Back to Selection